unblind


Also found in: Medical.

unblind

(ʌnˈblaɪnd)
adj
archaic not blind
vb (tr)
to rid (someone) of blindness
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Mentioned in ?
References in periodicals archive ?
The company plans to unblind the AIM2CERV clinical data generated to date and anticipates submitting these data for publication.
In addition to a decline in core operating profit, the corresponding period of the previous year saw a reversal of expenses resulting from the decreased fair value of contingent consideration following the Company's decision to unblind the global Phase 3 study of napabucasin for gastric and gastro-esophageal junction cancer patients, which is under development by Boston Biomedical, Inc.
The CEO of NWBio commented: "We are excited to see how the data are maturing, and we are grateful to our Scientific Advisory Board for their strong advice not to unblind the trial too early.
unblind precued choice RT push [48] sham controlled button right hand Mannarelli 79% 12 Crossover Precued choice RT push et al.
Each scan is annotated by up to 4 radiologists in a two-phase annotation process (blind and unblind).
I still remember when the statistician pressed the button to unblind the trial.
He concludes that "the two factors most likely to influence the behavior of French jurors were their extreme harshness towards property crimes and their relative indifference to violent crimes" ("Justice Unblind" 91).
Depending on the success of the company's efforts to pursue strategic options for continuing its clinical programs, the company may determine to conclude the study beyond December 31 and unblind the study data at the assessments of the primary efficacy endpoint, i.e., 90 days post treatment of the last enrolled patient.
Enactment of speculative non-buddhist heuristics enables the Buddhist to unbind and unblind from the coercive yet largely unconscious effects of the charism.
Based on the FDA guidance, the Company will now unblind the trial results after the final follow-up safety visit instead of after the primary efficacy endpoint, as previously planned.